Yu Zou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yu Zou has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
Kui Li
Department of Radiology, Women’S Hospital, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Hangzhou, China
8 shared publicationsGuohui Yan
Department of Radiology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
6 shared publicationsXiaodan Zhang
Department of Radiology, Women's Hospital, Zhejiang University School of Medicine, Zhejiang, China
5 shared publicationsMeixiang Deng
Department of Radiology, Women’S Hospital, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Hangzhou, China
4 shared publicationsWeizeng Zheng
Department of Radiology Women's Hospital School of Medicine Zhejiang University Hangzhou China
4 shared publications- Dan Wu
Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University
3 shared publications
Latest Publications
- Open Access
- 21 September 2026
- Published by Springer Nature in Insights into Imaging
- Vol. 17 (1) , 232
MRI insights into endometrial stromal tumors
Preoperative misdiagnosis and the adoption of incorrect surgical approaches occur frequently in patients with endometrial stromal tumors (ESTs) because of their rarity, nonspecific clinical manifestations, and imaging features that highly overlap with those of other benign uterine tumors, thereby increasing the risk of secondary surgery and adverse outcomes. Thus, accurate diagnosis is essential, and following initial clinical and sonographic assessments, MRI serves as the cornerstone imaging technique for further characterization and differential diagnosis. Radiologists must be familiar with and adept at interpreting these images to narrow the differential diagnosis and at least suggest the possibility of EST. This article describes the imaging manifestations of various ESTs and highlights characteristic radiological features that enable radiologists to refine the differential diagnosis, thereby assisting clinicians in determining appropriate treatment strategies. Key Points: Question Preoperative differentiation of ESTs from benign uterine lesions remains challenging and may result in the adoption of the incorrect surgical approach. Findings Key MRI features include homogeneous T2WI hyperintensity without speckles, T2WI hypointense bands, a worm‑like appearance, multilocular cystic changes, and feather‑like enhancement. Critical Relevance Statement This review comprehensively describes the MRI findings of ESTs and provides an educational summary based on tumor location, morphology, and key features to substantially improve diagnostic confidence.
- 21 September 2026
- Published by Springer Nature in Insights into Imaging
- Vol. 17 (1) , 232
Open AccessMRI insights into endometrial stromal tumors
Preoperative misdiagnosis and the adoption of incorrect surgical approaches occur frequently in patients with endometrial stromal tumors (ESTs) because of their rarity, nonspecific clinical manifestations, and imaging features that highly overlap with those of other benign uterine tumors, thereby increasing the risk of secondary surgery and adverse outcomes. Thus, accurate diagnosis is essential, and following initial clinical and sonographic assessments, MRI serves as the cornerstone imaging technique for further characterization and differential diagnosis. Radiologists must be familiar with and adept at interpreting these images to narrow the differential diagnosis and at least suggest the possibility of EST. This article describes the imaging manifestations of various ESTs and highlights characteristic radiological features that enable radiologists to refine the differential diagnosis, thereby assisting clinicians in determining appropriate treatment strategies. Key Points: Question Preoperative differentiation of ESTs from benign uterine lesions remains challenging and may result in the adoption of the incorrect surgical approach. Findings Key MRI features include homogeneous T2WI hyperintensity without speckles, T2WI hypointense bands, a worm‑like appearance, multilocular cystic changes, and feather‑like enhancement. Critical Relevance Statement This review comprehensively describes the MRI findings of ESTs and provides an educational summary based on tumor location, morphology, and key features to substantially improve diagnostic confidence.
- Open Access
- 26 January 2026
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 319, 114975
MRI in the incarceration of the gravid uterus: From diagnosis to individualized management
- 26 January 2026
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 319, 114975
Open AccessMRI in the incarceration of the gravid uterus: From diagnosis to individualized management
- Open Access
- 20 March 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1-10
A machine learning model based on placental magnetic resonance imaging and clinical factors to predict fetal growth restriction
To create a placental radiomics-clinical machine learning model to predict FGR. Retrospectively analyzed placental MRI and clinical data of 110 FGR cases and 158 healthy controls at 28–37 weeks of gestation from two campuses of ZWH. 227 cases from Hubin campus were randomly divided into training (n = 182) and internal testing set (n = 45). 41 cases from Xiaoshan campus were included in external testing set. Placental MRI features were extracted from sagittal T2WI. Mann–Whitney U test, redundancy analysis, and LASSO were used to identify the radiomics signature, and the best-performing radiomics model was constructed by comparing eight machine learning algorithms. Clinical factors determined by univariate and multivariate analyses. A united model and nomogram combining the radiomics Rad-score and clinical factors were established. The performance of the models was assessed by DeLong test, calibration curve and decision curve analysis. Of 1561 radiomics features, 10 strongly correlated with FGR were selected. The radiomics model using logistic regression performed best compared eight algorithms. 5 important clinical features identified by analysis. The united model demonstrated a good predictive performance in the training, internal testing and external testing sets, with AUC 0.941 (95% CI, 0.0.904–0.977), 0.899 (95% CI, 0.789–1) and 0.861 (95% CI 0.725–0.998), prediction accuracies 0.885, 0.844 and 0.805, precisions 0.871, 0.789 and 0.867, recalls 0.836, 0.833 and 0.684, and F1 scores 0.853, 0.811 and 0.765, respectively. The calibration and decision curves of the united model also showed good performance. Nomogram confirmed clinical applicability of the model. The proposed placental radiomics-clinical machine learning model is simple yet effective to predict FGR.
- 20 March 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1-10
Open AccessA machine learning model based on placental magnetic resonance imaging and clinical factors to predict fetal growth restriction
To create a placental radiomics-clinical machine learning model to predict FGR. Retrospectively analyzed placental MRI and clinical data of 110 FGR cases and 158 healthy controls at 28–37 weeks of gestation from two campuses of ZWH. 227 cases from Hubin campus were randomly divided into training (n = 182) and internal testing set (n = 45). 41 cases from Xiaoshan campus were included in external testing set. Placental MRI features were extracted from sagittal T2WI. Mann–Whitney U test, redundancy analysis, and LASSO were used to identify the radiomics signature, and the best-performing radiomics model was constructed by comparing eight machine learning algorithms. Clinical factors determined by univariate and multivariate analyses. A united model and nomogram combining the radiomics Rad-score and clinical factors were established. The performance of the models was assessed by DeLong test, calibration curve and decision curve analysis. Of 1561 radiomics features, 10 strongly correlated with FGR were selected. The radiomics model using logistic regression performed best compared eight algorithms. 5 important clinical features identified by analysis. The united model demonstrated a good predictive performance in the training, internal testing and external testing sets, with AUC 0.941 (95% CI, 0.0.904–0.977), 0.899 (95% CI, 0.789–1) and 0.861 (95% CI 0.725–0.998), prediction accuracies 0.885, 0.844 and 0.805, precisions 0.871, 0.789 and 0.867, recalls 0.836, 0.833 and 0.684, and F1 scores 0.853, 0.811 and 0.765, respectively. The calibration and decision curves of the united model also showed good performance. Nomogram confirmed clinical applicability of the model. The proposed placental radiomics-clinical machine learning model is simple yet effective to predict FGR.
- 19 September 2024
- Published by Springer Nature in European Radiology
- Vol. 35 (4) , 1830-1842
Site effects in multisite fetal brain MRI: morphological insights into early brain development
Objective To evaluate multisite effects on fetal brain MRI. Specifically, to identify crucial acquisition factors affecting fetal brain structural measurements and developmental patterns, while assessing the effectiveness of existing harmonization methods in mitigating site effects. Materials and methods Between May 2017 and March 2022, T2-weighted fast spin-echo sequences in-utero MRI were performed on healthy fetuses from retrospectively recruited pregnant volunteers on four different scanners at four sites. A generalized additive model (GAM) was used to quantitatively assess site effects, including field strength (FS), manufacturer (M), in-plane resolution (R), and slice thickness (ST), on subcortical volume and cortical morphological measurements, including cortical thickness, curvature, and sulcal depth. Growth models were selected to elucidate the developmental trajectories of these morphological measurements. Welch’s test was performed to evaluate the influence of site effects on developmental trajectories. The comBat-GAM harmonization method was applied to mitigate site-related biases. Results The final analytic sample consisted of 340 MRI scans from 218 fetuses (mean GA, 30.1 weeks ± 4.4 [range, 21.7–40 weeks]). GAM results showed that lower FS and lower spatial resolution led to overestimations in selected brain regions of subcortical volumes and cortical morphological measurements. Only the peak cortical thickness in developmental trajectories was significantly influenced by the effects of FS and R. Notably, ComBat-GAM harmonization effectively removed site effects while preserving developmental patterns. Conclusion Our findings pinpointed the key acquisition factors in in-utero fetal brain MRI and underscored the necessity of data harmonization when pooling multisite data for fetal brain morphology investigations. Key Points Question How do specific site MRI acquisition factors affect fetal brain imaging? Finding Lower FS and spatial resolution overestimated subcortical volumes and cortical measurements. Cortical thickness in developmental trajectories was influenced by FS and in-plane resolution. Clinical relevance This study provides important guidelines for the fetal MRI community when scanning fetal brains and underscores the necessity of data harmonization of cross-center fetal studies.
- 19 September 2024
- Published by Springer Nature in European Radiology
- Vol. 35 (4) , 1830-1842
Site effects in multisite fetal brain MRI: morphological insights into early brain development
Objective To evaluate multisite effects on fetal brain MRI. Specifically, to identify crucial acquisition factors affecting fetal brain structural measurements and developmental patterns, while assessing the effectiveness of existing harmonization methods in mitigating site effects. Materials and methods Between May 2017 and March 2022, T2-weighted fast spin-echo sequences in-utero MRI were performed on healthy fetuses from retrospectively recruited pregnant volunteers on four different scanners at four sites. A generalized additive model (GAM) was used to quantitatively assess site effects, including field strength (FS), manufacturer (M), in-plane resolution (R), and slice thickness (ST), on subcortical volume and cortical morphological measurements, including cortical thickness, curvature, and sulcal depth. Growth models were selected to elucidate the developmental trajectories of these morphological measurements. Welch’s test was performed to evaluate the influence of site effects on developmental trajectories. The comBat-GAM harmonization method was applied to mitigate site-related biases. Results The final analytic sample consisted of 340 MRI scans from 218 fetuses (mean GA, 30.1 weeks ± 4.4 [range, 21.7–40 weeks]). GAM results showed that lower FS and lower spatial resolution led to overestimations in selected brain regions of subcortical volumes and cortical morphological measurements. Only the peak cortical thickness in developmental trajectories was significantly influenced by the effects of FS and R. Notably, ComBat-GAM harmonization effectively removed site effects while preserving developmental patterns. Conclusion Our findings pinpointed the key acquisition factors in in-utero fetal brain MRI and underscored the necessity of data harmonization when pooling multisite data for fetal brain morphology investigations. Key Points Question How do specific site MRI acquisition factors affect fetal brain imaging? Finding Lower FS and spatial resolution overestimated subcortical volumes and cortical measurements. Cortical thickness in developmental trajectories was influenced by FS and in-plane resolution. Clinical relevance This study provides important guidelines for the fetal MRI community when scanning fetal brains and underscores the necessity of data harmonization of cross-center fetal studies.
- Open Access
- 19 August 2024
- Published by Springer Nature in Research Square
A machine learning model based on placental magnetic resonance imaging and clinical factors to predict fetal growth restriction
Objectives To create a placental radiomics-clinical machine learning model to predict FGR. Materials and Methods Retrospectively analyzed placental MRI and clinical data of 110 FGR cases and 158 healthy controls from two campuses of ZWH. 227 cases from Hubin campus were randomly divided into training (n = 182) and internal testing set (n = 45). 41 cases from Xiaoshan campus were included in external testing set. Placental MRI features were extracted from sagittal T2WI. Mann-Whitney U test, redundancy analysis, and LASSO were used to identify the radiomics signature, and the best-performing radiomics model was constructed by comparing eight machine learning algorithms. Clinical factors determined by univariate and multivariate analyses. A united model and nomogram combining the radiomics Rad-score and clinical factors were established. The performance of the models was assessed by DeLong test, calibration curve and decision curve analysis. Results Of 1561 radiomics features, 10 strongly correlated with FGR were selected. The radiomics model using logistic regression performed best compared eight algorithms. 5 important clinical features identified by analysis. The united model demonstrated a good predictive performance in the training, internal testing and external testing sets, with AUC 0.941 (95% CI, 0.0.904–0.977), 0.899 (95% CI, 0.789–1) and 0.861 (95% CI 0.725–0.998), prediction accuracies 0.885, 0.844 and 0.805, precisions 0.871, 0.789 and 0.867, recalls 0.836, 0.833 and 0.684, and F1 scores 0.853, 0.811 and 0.765, respectively. The calibration and decision curves of the united model also showed good performance. Nomogram confirmed clinical applicability of the model. Conclusions The proposed placental radiomics-clinical machine learning model is simple yet effective to predict FGR.
- 19 August 2024
- Published by Springer Nature in Research Square
Open AccessA machine learning model based on placental magnetic resonance imaging and clinical factors to predict fetal growth restriction
Objectives To create a placental radiomics-clinical machine learning model to predict FGR. Materials and Methods Retrospectively analyzed placental MRI and clinical data of 110 FGR cases and 158 healthy controls from two campuses of ZWH. 227 cases from Hubin campus were randomly divided into training (n = 182) and internal testing set (n = 45). 41 cases from Xiaoshan campus were included in external testing set. Placental MRI features were extracted from sagittal T2WI. Mann-Whitney U test, redundancy analysis, and LASSO were used to identify the radiomics signature, and the best-performing radiomics model was constructed by comparing eight machine learning algorithms. Clinical factors determined by univariate and multivariate analyses. A united model and nomogram combining the radiomics Rad-score and clinical factors were established. The performance of the models was assessed by DeLong test, calibration curve and decision curve analysis. Results Of 1561 radiomics features, 10 strongly correlated with FGR were selected. The radiomics model using logistic regression performed best compared eight algorithms. 5 important clinical features identified by analysis. The united model demonstrated a good predictive performance in the training, internal testing and external testing sets, with AUC 0.941 (95% CI, 0.0.904–0.977), 0.899 (95% CI, 0.789–1) and 0.861 (95% CI 0.725–0.998), prediction accuracies 0.885, 0.844 and 0.805, precisions 0.871, 0.789 and 0.867, recalls 0.836, 0.833 and 0.684, and F1 scores 0.853, 0.811 and 0.765, respectively. The calibration and decision curves of the united model also showed good performance. Nomogram confirmed clinical applicability of the model. Conclusions The proposed placental radiomics-clinical machine learning model is simple yet effective to predict FGR.
- Open Access
- 14 June 2023
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 59 (4) , 1384-1393
Diffusion‐Weighted MRI of the Fetal Brain in Fetal Growth Restriction With Maternal Preeclampsia or Gestational Hypertension
Background: The fetal neurodevelopmental microstructural alterations of intrauterine exposure to preeclampsia (PE) or gestational hypertension (GH) remain unknown.Purpose: To evaluate the differences in diffusion‐weighted imaging (DWI) of the fetal brain between normotensive pregnancies and PE/GH pregnancies, with a focus on PE/GH pregnancies with fetal growth restriction (FGR).Study Type: Retrospective matched case–control study.Population: 40 singleton pregnancies with PE/GH complicated by FGR, and 3 paired control groups (PE/GH without FGR, normotensive FGR, normotensive pregnancies) (28–38 gestational weeks).Field Strength/Sequence: DWI with single‐shot echo‐planar imaging at 1.5 Tesla.Assessment: The apparent diffusion coefficient (ADC) values were calculated in the centrum semi‐ovale (CSO), parietal white matter (PWM), frontal white matter (FWM), occipital white matter (OWM), temporal white matter (TWM), basal ganglia, thalamus (THAL), pons, and cerebellar hemisphere.Statistical Tests: Student t test or Wilcoxon matched test was used to reveal the difference of ADC values among the investigated brain regions. A correlation between gestational age (GA) and ADC values was determined by linear regression analysis.Results: Compared with fetuses in PE/GH without FGR and those with normotensive pregnancies, fetuses in the PE/GH with FGR group had significantly lower average ADC measurements of supratentorial regions (1.65 ± 0.09 vs. 1.71 ± 0.10 10−3 mm2/sec; vs. 1.73 ± 0.11 10−3 mm2/sec, respectively). Regions of significantly decreased ADC values in the fetal brain included CSO, FWM, PWM, OWM, TWM and THAL in cases of PE/GH with FGR. ADC values from supratentorial regions in PE/GH pregnancies were not significantly correlated with GA (P = 0.12, 0.26); however, this trend was statistically significant in the normotensive groups.Data Conclusion: ADC values may indicate fetal brain developmental alterations in PE/GH with FGR fetuses but more microscopic and morphological studies are necessary to provide additional evidence to offer a different interpretation of this trend in fetal brain.Level of Evidence: 4Technical Efficacy Stage: 3
- 14 June 2023
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 59 (4) , 1384-1393
Open AccessDiffusion‐Weighted MRI of the Fetal Brain in Fetal Growth Restriction With Maternal Preeclampsia or Gestational Hypertension
Background: The fetal neurodevelopmental microstructural alterations of intrauterine exposure to preeclampsia (PE) or gestational hypertension (GH) remain unknown.Purpose: To evaluate the differences in diffusion‐weighted imaging (DWI) of the fetal brain between normotensive pregnancies and PE/GH pregnancies, with a focus on PE/GH pregnancies with fetal growth restriction (FGR).Study Type: Retrospective matched case–control study.Population: 40 singleton pregnancies with PE/GH complicated by FGR, and 3 paired control groups (PE/GH without FGR, normotensive FGR, normotensive pregnancies) (28–38 gestational weeks).Field Strength/Sequence: DWI with single‐shot echo‐planar imaging at 1.5 Tesla.Assessment: The apparent diffusion coefficient (ADC) values were calculated in the centrum semi‐ovale (CSO), parietal white matter (PWM), frontal white matter (FWM), occipital white matter (OWM), temporal white matter (TWM), basal ganglia, thalamus (THAL), pons, and cerebellar hemisphere.Statistical Tests: Student t test or Wilcoxon matched test was used to reveal the difference of ADC values among the investigated brain regions. A correlation between gestational age (GA) and ADC values was determined by linear regression analysis.Results: Compared with fetuses in PE/GH without FGR and those with normotensive pregnancies, fetuses in the PE/GH with FGR group had significantly lower average ADC measurements of supratentorial regions (1.65 ± 0.09 vs. 1.71 ± 0.10 10−3 mm2/sec; vs. 1.73 ± 0.11 10−3 mm2/sec, respectively). Regions of significantly decreased ADC values in the fetal brain included CSO, FWM, PWM, OWM, TWM and THAL in cases of PE/GH with FGR. ADC values from supratentorial regions in PE/GH pregnancies were not significantly correlated with GA (P = 0.12, 0.26); however, this trend was statistically significant in the normotensive groups.Data Conclusion: ADC values may indicate fetal brain developmental alterations in PE/GH with FGR fetuses but more microscopic and morphological studies are necessary to provide additional evidence to offer a different interpretation of this trend in fetal brain.Level of Evidence: 4Technical Efficacy Stage: 3
- 20 November 2022
- Published by Wolters Kluwer Health in Menopause
- Vol. 30 (2) , 122-127
Loss of muscle mass in women with premature ovarian insufficiency as compared with healthy controls
Objective: Menopausal transition has been known to be associated with the loss of muscle mass. However, muscle health in women with premature menopause, that is, premature ovarian insufficiency (POI), remains unclear. We aimed to investigate and compare muscle mass parameters and the prevalence of low muscle mass between patients with spontaneous POI and healthy controls. Methods: In this cross-sectional study, 59 women with spontaneous POI and 57 premenopausal controls with normal ovarian function were enrolled at the Women's Hospital, Zhejiang University School of Medicine (Hangzhou, China) from June 17, 2020, to August 20, 2021. Muscle mass parameters were measured by dual-energy x-ray absorptiometry, and low muscle mass was diagnosed using the Asian Working Group for Sarcopenia criteria. In addition, participants provided their sociodemographic data, menstrual and reproductive history, lifestyle factors, and medical history. Multivariate linear regression analysis was conducted. Results: Muscle mass parameters, including appendicular skeletal muscle mass (ASM), ASM/height2, ASM/weight, ASM/body mass index, total skeletal muscle mass (TSM), and TSM/weight, were significantly lower in women with POI as compared with healthy controls (ASM: 14.62 ± 2.08 vs 15.97 ± 1.78, P < 0.001; ASM/height2: 5.71 ± 0.64 vs 6.15 ± 0.62, P < 0.001; ASM/weight: 0.27 [0.25, 0.28] vs 0.28 [0.27, 0.29], P = 0.002; ASM/BMI: 0.68 ± 0.07 vs 0.73 ± 0.06, P = 0.001; TSM: 33.85 ± 4.08 vs 36.43 ± 3.56, P < 0.001; TSM/weight: 0.63 [0.59, 0.65] vs 0.64 [0.61, 0.67], P = 0.02). The prevalence of low muscle mass in POI patients was significantly higher than that in controls (32.20% vs 8.77%, χ 2 = 9.70, P = 0.002). Furthermore, multivariate linear regression analyses demonstrated that POI status was an independent risk factor for ASM (β = −1.13; 95% CI, −1.62 to −0.65), ASM/height2 (−0.35, −0.47 to −0.22), ASM/weight (−0.01, −0.02 to −0.009), ASM/BMI (−0.05, −0.07 to −0.02), TSM (−2.16, −3.14 to −1.17), and TSM/weight (−0.03, −0.04 to −0.02). Conclusions: Women with POI exhibit significant loss of muscle mass as compared with healthy controls. Early diagnosis and long-term health management in POI patients are important.
- 20 November 2022
- Published by Wolters Kluwer Health in Menopause
- Vol. 30 (2) , 122-127
Loss of muscle mass in women with premature ovarian insufficiency as compared with healthy controls
Objective: Menopausal transition has been known to be associated with the loss of muscle mass. However, muscle health in women with premature menopause, that is, premature ovarian insufficiency (POI), remains unclear. We aimed to investigate and compare muscle mass parameters and the prevalence of low muscle mass between patients with spontaneous POI and healthy controls. Methods: In this cross-sectional study, 59 women with spontaneous POI and 57 premenopausal controls with normal ovarian function were enrolled at the Women's Hospital, Zhejiang University School of Medicine (Hangzhou, China) from June 17, 2020, to August 20, 2021. Muscle mass parameters were measured by dual-energy x-ray absorptiometry, and low muscle mass was diagnosed using the Asian Working Group for Sarcopenia criteria. In addition, participants provided their sociodemographic data, menstrual and reproductive history, lifestyle factors, and medical history. Multivariate linear regression analysis was conducted. Results: Muscle mass parameters, including appendicular skeletal muscle mass (ASM), ASM/height2, ASM/weight, ASM/body mass index, total skeletal muscle mass (TSM), and TSM/weight, were significantly lower in women with POI as compared with healthy controls (ASM: 14.62 ± 2.08 vs 15.97 ± 1.78, P < 0.001; ASM/height2: 5.71 ± 0.64 vs 6.15 ± 0.62, P < 0.001; ASM/weight: 0.27 [0.25, 0.28] vs 0.28 [0.27, 0.29], P = 0.002; ASM/BMI: 0.68 ± 0.07 vs 0.73 ± 0.06, P = 0.001; TSM: 33.85 ± 4.08 vs 36.43 ± 3.56, P < 0.001; TSM/weight: 0.63 [0.59, 0.65] vs 0.64 [0.61, 0.67], P = 0.02). The prevalence of low muscle mass in POI patients was significantly higher than that in controls (32.20% vs 8.77%, χ 2 = 9.70, P = 0.002). Furthermore, multivariate linear regression analyses demonstrated that POI status was an independent risk factor for ASM (β = −1.13; 95% CI, −1.62 to −0.65), ASM/height2 (−0.35, −0.47 to −0.22), ASM/weight (−0.01, −0.02 to −0.009), ASM/BMI (−0.05, −0.07 to −0.02), TSM (−2.16, −3.14 to −1.17), and TSM/weight (−0.03, −0.04 to −0.02). Conclusions: Women with POI exhibit significant loss of muscle mass as compared with healthy controls. Early diagnosis and long-term health management in POI patients are important.
- Open Access
- 14 August 2021
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 21 (1) , 1-11
Alterations of brain metrics in fetuses of women with polycystic ovary syndrome : a retrospective study based on fetal magnetic resonance imaging
Background: Maternal polycystic ovary syndrome (PCOS) has potential detrimental effects on the neurodevelopment of offspring. This study aimed to evaluate the brain metrics in fetuses of women with PCOS based on fetal magnetic resonance imaging (MRI).Methods: This retrospective study included 60 pregnant women with PCOS (PCOS group) and 120 pregnant non-PCOS women (control group). Fetal MRI was performed followed an ultrasound and for numerous clinical indications including known or suspected fetal pathology, history of fetal abnormality in previous pregnancy or in a family member. Fetal brain biometry and apparent diffusion coefficient (ADC) value were analysed.Results: After adjusting for potential confounders, fetuses in the PCOS group showed the following characteristics compared to fetuses in the control group: (1) smaller cerebral fronto-occipital diameter (FOD), vermian height (VH) and anteroposterior diameter of the pons (APDP) (evident before 32 weeks;P = 0.042,P = 0.002 andP = 0.016, respectively); (2) larger left and right biparietal index (evident before 32 weeks;P = 0.048 andP = 0.025, respectively); (3) smaller left lateral ventricle (LV) (evident after 32 weeks;P = 0.005); (4) larger anteroposterior diameter of the vermis (APDV) and hippocampal infolding angle (HIA) (evident after 32 weeks;P = 0.003 andP < 0.001, respectively); (5) higher ADC value in frontal white matter (FWM) and in basal ganglia (BG) (evident before and after 32 weeks; allP < 0.05).Conclusions: There exist a different pattern of brain metrics in PCOS offspringin utero.
- 14 August 2021
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 21 (1) , 1-11
Open AccessAlterations of brain metrics in fetuses of women with polycystic ovary syndrome : a retrospective study based on fetal magnetic resonance imaging
Background: Maternal polycystic ovary syndrome (PCOS) has potential detrimental effects on the neurodevelopment of offspring. This study aimed to evaluate the brain metrics in fetuses of women with PCOS based on fetal magnetic resonance imaging (MRI).Methods: This retrospective study included 60 pregnant women with PCOS (PCOS group) and 120 pregnant non-PCOS women (control group). Fetal MRI was performed followed an ultrasound and for numerous clinical indications including known or suspected fetal pathology, history of fetal abnormality in previous pregnancy or in a family member. Fetal brain biometry and apparent diffusion coefficient (ADC) value were analysed.Results: After adjusting for potential confounders, fetuses in the PCOS group showed the following characteristics compared to fetuses in the control group: (1) smaller cerebral fronto-occipital diameter (FOD), vermian height (VH) and anteroposterior diameter of the pons (APDP) (evident before 32 weeks;P = 0.042,P = 0.002 andP = 0.016, respectively); (2) larger left and right biparietal index (evident before 32 weeks;P = 0.048 andP = 0.025, respectively); (3) smaller left lateral ventricle (LV) (evident after 32 weeks;P = 0.005); (4) larger anteroposterior diameter of the vermis (APDV) and hippocampal infolding angle (HIA) (evident after 32 weeks;P = 0.003 andP < 0.001, respectively); (5) higher ADC value in frontal white matter (FWM) and in basal ganglia (BG) (evident before and after 32 weeks; allP < 0.05).Conclusions: There exist a different pattern of brain metrics in PCOS offspringin utero.